Cargando…

Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma

BACKGROUND: Due to the difficulties in early diagnosing and treating hepatocellular carcinoma (HCC), prognoses for patients remained poor in the past decade. In this study, we established a screening model to discover novel prognostic biomarkers in HCC patients. METHODS: Candidate biomarkers were sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yi-Chieh, Chien, Ming-Hsien, Lai, Tsung-Ching, Tung, Min-Che, Jan, Yi-Hua, Chang, Wei-Ming, Jung, Shih-Ming, Chen, Ming-Huang, Yeh, Chun-Nan, Hsiao, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063382/ https://www.ncbi.nlm.nih.gov/pubmed/33888099 http://dx.doi.org/10.1186/s12929-021-00727-5

Ejemplares similares

A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation
por: Lee, Pei-Chang, et al.
Publicado: (2020)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

Monoamine Oxidase B Expression Correlates with a Poor Prognosis in Colorectal Cancer Patients and Is Significantly Associated with Epithelial-to-Mesenchymal Transition-Related Gene Signatures
por: Yang, Yi-Chieh, et al.
Publicado: (2020)

Poor Prognoses of Young Hepatocellular Carcinoma Patients with Microvascular Invasion: A Propensity Score Matching Cohort Study
por: Li, Lian, et al.
Publicado: (2020)

The circular RNA CDR1as regulate cell proliferation via TMED2 and TMED10
por: Yang, Xue, et al.
Publicado: (2020)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

A Comparison of Clinical Manifestations and Prognoses Between Patients with Hepatocellular Carcinoma and Child–Pugh Scores of 5 or 6
por: Hung, Hung-Hsu, et al.
Publicado: (2014)

Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
por: Ho, Kuo-Hao, et al.
Publicado: (2021)

An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma
por: Yang, Ming, et al.
Publicado: (2022)

Unconventional secretion: cargo channeling by TMED10
por: Nguyen, Tan A., et al.
Publicado: (2020)

TMED family genes and their roles in human diseases
por: Zhou, Lv, et al.
Publicado: (2023)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis
por: Xu, Liangliang, et al.
Publicado: (2022)

Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer
por: Lee, Yu-Chieh, et al.
Publicado: (2015)

TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
por: Zheng, Hao, et al.
Publicado: (2016)

TMED2 promotes epithelial ovarian cancer growth
por: Shi-Peng, Gong, et al.
Publicado: (2017)

Expression and Importance of TMED2 in Multiple Myeloma Cells
por: Ge, Xueling, et al.
Publicado: (2020)

Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022)

High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy
por: Chen, Tzu-Ju, et al.
Publicado: (2018)

Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses
por: Yin, Liang-Chun, et al.
Publicado: (2018)

A Macrophage Differentiation-Mediated Gene: DDX20 as a Molecular Biomarker Encompassing the Tumor Microenvironment, Disease Staging, and Prognoses in Hepatocellular Carcinoma
por: Yang, Yi, et al.
Publicado: (2022)

TMED2 as a marker of prognosis in breast cancer [Letter]
por: Schwarz, Megan Catherine, et al.
Publicado: (2019)

Expression of TMED3 is independently associated with colorectal cancer prognosis
por: Wang, Rong-Fei, et al.
Publicado: (2022)

TMED2 binding restricts SMO to the ER and Golgi compartments
por: Di Minin, Giulio, et al.
Publicado: (2022)

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer
por: Fang, Zheng, et al.
Publicado: (2022)

Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
por: Gu, Yu, et al.
Publicado: (2023)

Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2012)

Correction: Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2017)

Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients
por: Wang, Yu-peng, et al.
Publicado: (2015)

The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases
por: Mishra, Sonakshi, et al.
Publicado: (2019)

Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancer
por: Yeh, Chien-Chih, et al.
Publicado: (2019)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
por: Liu, Yi-Sheng, et al.
Publicado: (2015)

High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer
por: Liu, Dan, et al.
Publicado: (2017)

RAB21 interacts with TMED10 and modulates its localization and abundance
por: Del Olmo, Tomas, et al.
Publicado: (2019)

Trafficking protein TMED3 promotes esophageal squamous cell carcinoma
por: Yang, Yuxian, et al.
Publicado: (2023)

Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis
por: Tung, Min-Che, et al.
Publicado: (2022)

Impact of comorbidities on the prognoses of trauma patients: Analysis of a hospital-based trauma registry database
por: Wang, Chih-Yuan, et al.
Publicado: (2018)

eIF4E Overexpression Is Associated with Poor Prognoses of Ovarian Cancer
por: Zheng, Jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4vh786rmvu0e88nnb5p9eeptgs